Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Review of Anticancer Therapy|July 22, 2010
Should prostate-specific antigen screening be offered to asymptomatic men?Heidi A van Vugt, Chris H Bangma, Monique J Roobol
Patient Preference and Adherence|January 16, 2019
Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulinHeidi A van Vugt, Anne Meike Boels, Inge de Weerdt, et al.
Patient Preference and Adherence|April 4, 2022
Key Factors Relevant for Healthcare Decisions of Patients with Type 1 and Type 2 Diabetes in Secondary Care According to Healthcare ProfessionalsMerel M Ruissen, Jacob K Sont, Heidi A van Vugt, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2010
Prediction of prostate cancer in unscreened men: external validation of a risk calculatorHeidi A van Vugt, Monique J Roobol, Ries Kranse, et al.
BJU International|July 15, 2009
Disease insight and treatment perception of men on active surveillance for early prostate cancerRoderick C N van den Bergh, Heidi A van Vugt, Ida J Korfage, et al.
BJU International|September 22, 2011
Compliance with biopsy recommendations of a prostate cancer risk calculatorHeidi A van Vugt, Monique J Roobol, Martijn Busstra, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicatorHeidi A van Vugt, Monique J Roobol, Lionne D F Venderbos, et al.
European Urology|November 23, 2011
Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculatorsMonique J Roobol, Heidi A van Vugt, Stacy Loeb, et al.
Pageof 2